参考文献/References:
[1]Mody K,Bekaii-Saab T.Clinical Trials and Progress in Metastatic Colon Cancer[J].Surgical Oncology Clinics of North America,2018,27(2):349-365.[2]Lee JJ,Chu E.An update on treatment advances for the first-line therapy of metastatic colorectal cancer[J].Cancer Journal,2007,13(5):276-281.[3]Dennis G,Sherman B,Da H,et al.DAVID: Database for Annotation, Visualization, and Integrated Discovery[J].Genome Biology,2003,4(5):P3.[4]Shannon P.Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks[J].Genome Research,2003,13(11):2498-2504.[5]Bader GD,Hogue CWV.An Automated Method for Finding Molecular Complexes in Large Protein Interaction Networks[J].BMC Bioinformatics,2003,4(1,article 2):2.[6]Schulc K,Nagy ZT,Kamp S,et al.Modular Reorganization of Signaling Networks during the Development of Colon Adenoma and Carcinoma[J].The Journal of Physical Chemistry B,2021,125(7):1716-1726.[7]Cai Y,Sheng Z,Chen Y,et al.LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis[J].Aging,2019,11(10):3041-3054.[8]Li X,Zuo H,Zhang L,et al.Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods[J].Frontiers in Oncology,2021,11:3379.[9]吴良银,李文丽,刘俊.HMMR预测肝细胞癌预后的生物信息学分析[J].国际检验医学杂志,2022,43(12):1454-1457.[10]Xu F,Guan Y,Xue L,et al.The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma[J].BMC Cancer,2020,20(1):1207.[11]He Z,Mei L,Connell M,et al.Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor[J].Cells,2020,9(4):819.[12]Chen H,Connell M,Mei L,et al.The non-motor adaptor HMMR dampens Eg5-mediated forces to preserve the kinetics and integrity of chromosome segregation[J].Molecular Biology of the Cell,2018,29(7):786-796.[13]Rui Z,Roostalu J,Surrey T,et al.Structural insight into TPX2-stimulated microtubule assembly[J].Elife,2017,6:e30959.[14]He Z,Mei L,Connell M,et al.Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor[J].Cells,2020,9(4):819.[15]熊超.结肠癌组织中RNF181、TPX2的表达量及其与癌细胞活力、血管新生的相关性分析[J].海南医学院学报,2017,23(14):1969-1971,1975.[16]Wei P,Zhang N,Xu Y,et al.TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer[J].Journal of Translational Medicine,2013,1(1):313.[17]Janku F,Yap TA,Meric-Bernstam F.Targeting the PI3K pathway in cancer: are we making headway?[J].Nat Rev Clin Oncol,2018,15(5):273-291.[18]胡晓青,于慧美,沈璐妍,等.PI3K/AKT/mTOR信号通路与线粒体稳态在疾病治疗中的作用[J].中国病理生理杂志,2021,37(11):2072-2076.[19]Liu M,Ran J,Zhou J.Non-canonical functions of the mitotic kinesin Eg5[J].Thoracic Cancer,2018,9(8):904-910.[20]Chu TLH,Connell M,Zhou L,et al.Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A[J].Molecular Cancer Research,2018,16(1):16-31.[21]Taherdangkoo K,Kazemi Nezhad SR,Hajjari MR,et al.miR-485-3p suppresses colorectal cancer via targeting TPX2[J].Bratisl Lek Listy,2020,121(4):302-307.[22]熊超.结肠癌组织中RNF181、TPX2的表达量及其与癌细胞活力、血管新生的相关性分析[J].海南医学院学报,2017,23(14):1969-1971,1975.
相似文献/References:
[1]苏周荣,杜东霖,魏正强.左半结肠癌伴梗阻一期切除吻合策略研究[J].医学信息,2018,31(10):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
SU Zhou-rong,DU Dong-lin,WEI Zheng-qiang.Strategy of One-stage Resection and Anastomosis for Left Colon Cancer with Obstruction[J].Journal of Medical Information,2018,31(12):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
[2]崔忠泽,何 双,路丽祯,等.基于生物信息学分析筛选结肠癌关键基因[J].医学信息,2022,35(10):1.[doi:10.3969/j.issn.1006-1959.2022.10.001]
CUI Zhong-ze,HE Shuang,LU Li-zhen,et al.Screening Key Genes of Colon Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(12):1.[doi:10.3969/j.issn.1006-1959.2022.10.001]
[3]石 磊,孙新增,李宝山,等.Ⅱ、Ⅲ期结肠癌患者辅助化疗XELOX方案、FOLFOX方案的临床疗效、不良反应及生活质量对比[J].医学信息,2018,31(13):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
SHI Lei,SUN Xin-zeng,LI Bao-shan,et al.Clinical Efficacy,Adverse Reactions and Quality of Life of Adjuvant Chemotherapy XELOX and FOLFOX in Patients with Stage II and III Colon Cancer[J].Journal of Medical Information,2018,31(12):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
[4]王 超,范小华,张 力,等.下腔静脉畸形伴腹腔多脏器异位合并结肠癌1例[J].医学信息,2018,31(18):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
WANG Chao,FAN Xiao-hua,ZHANG Li,et al.a Case of Inferior Vena Cava Malformation Associated with Multiple Abdominal Organ Ectopic Colon Cancer[J].Journal of Medical Information,2018,31(12):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
[5]操利超,张核子,余晨笛,等.CLDN11在结肠癌中的预后价值及其作为潜在免疫治疗靶点的研究[J].医学信息,2022,35(14):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
CAO Li-chao,ZHANG He-zi,YU Chen-di,et al.The Prognostic Value of CLDN11 in Colon Cancer and its Potential Immunotherapy Targets[J].Journal of Medical Information,2022,35(12):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
[6]黄富全.结合靶向药物综合治疗结肠癌肝及肝外转移术后7年1例报告[J].医学信息,2019,32(01):186.[doi:10.3969/j.issn.1006-1959.2019.01.061]
[7]葛菁茹,朱静雅,苏日新,等.以肺转移为首发表现的结肠癌预后分析[J].医学信息,2021,34(04):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
GE Jing-ru,ZHU Jing-ya,SU Ri-xin,et al.Prognostic Analysis of Colon Cancer with Lung Metastasis as the First Manifestation[J].Journal of Medical Information,2021,34(12):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
[8]韩 猛,薛三宝,倪 丰.CT与MRI术前诊断结肠癌及评价术后复发的价值[J].医学信息,2021,34(21):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
HAN Meng,XUE San-bao,NI Feng.Value of CT and MRI in Preoperative Diagnosis and Postoperative Recurrence of Colon Cancer[J].Journal of Medical Information,2021,34(12):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
[9]操利超,巴 颖,卢晓萍,等.基于TCGA和GEO数据库构建结肠癌预后模型[J].医学信息,2021,34(24):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]
CAO Li-chao,BA Ying,LU Xiao-ping,et al.Prognostic Model of Colon Cancer Based on TCGA and GEO Database[J].Journal of Medical Information,2021,34(12):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]
[10]张秀娟,黄丽娟.mTOR、PTEN、Ki-67蛋白表达水平变化与结肠癌病理学特征的相关性分析[J].医学信息,2022,35(19):54.[doi:10.3969/j.issn.1006-1959.2022.19.014]
ZHANG Xiu-juan,HUANG Li-juan.Correlation of mTOR, PTEN and Ki-67 Protein Expression with Pathological Features of Colon Cancer[J].Journal of Medical Information,2022,35(12):54.[doi:10.3969/j.issn.1006-1959.2022.19.014]